New DOD Ovarian Cancer Research Program Clinical Trial Award, Letters of Intent Due June 22

The Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) is offering a new Clinical Trial Award with $1.5 million in available funds for FY 2022. Letters of intent for this award are due June 22, 2022, by 5:00 p.m. EDT, and applications are due August 5, 2022, by 11:59 p.m. EDT.

The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Independent investigators at all academic levels are eligible to apply for this new award. More information and application instructions can be found online.